This review highlights the clinical significance of high residual platelet reactivity on clopidogrel and explores strategies to quantify and overcome it to prevent recurrent ischemic events.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for reactivity-guided therapy; leaves open whether testing improves outcomes in practice.
Garabedian et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: